Beaten-Down Biotech Just Lost a Backer — Should You Care
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Some index funds distribute fewer capital gains than others, which can reduce tax surprises and improve after-tax performance over time.
28,126 articlesWhen a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Balancing college funding for your kids with your retirement goals can feel impossible. This guide shows a practical ...
Investors are shifting bets toward defense names as urban warfare tech dominates modernization plans. This piece exam...
GTS Securities recently sold a large chunk of its XOVR exposure, shedding about 19.46 million shares worth roughly 35...
A notable investor exited a large Ethereum ETF and pivoted toward Bitcoin last quarter. This article explains what su...
Two CoinDCX co-founders were arrested by Indian police amid a fraud probe. The company denies wrongdoing and blames i...
A major fund trimmed its AvePoint stake, triggering a sharp move in AVPT. This piece breaks down what happened, why i...
The SEC proposes letting companies use semiannual reports to meet interim disclosure duties, potentially easing burde...
Progressive is more than its ads. This article shows how underwriting profits interact with float income, and why ris...
The Zcash network halted block production for more than four hours, leaving thousands of transactions stranded and se...
A high-conviction AI bet is reshaping how Ackman runs his hedge fund. Learn why nearly 40% of his capital sits in thr...
As crypto markets swing through July 2026, traders weigh HYPE against XRP, focusing on price, ETF access, and long-te...